In addition, IL-18 has been observed to be able to induce release of IFN-γ, IL-13, and eotaxin in the lungs of ovalbumin-sensitized and challenged transgenic mice along with an increase in IL-13 producing CD4+ T cells and airway hyperresponsiveness [7]. The gene discussed is IL13; the disease is airway hyperresponsiveness.